Skip to main content

Table 1 Details of grade III GCT patients treated with autograft-prosthesis composite

From: Inactivated autograft–prosthesis composite have a role for grade III giant cell tumor of bone around the knee

Site Pathological fracture Status of tumor Follow-up (months) MSTS function score ISOLS image score Status at latest follow-up
Left distal femur No Recurrence 67 27 (90%) 33 (92%) Disease-free
Right distal femur No Recurrence 60 26 (87%) 35 (97%) Disease-free
Left distal femur Yes Primary 51 25 (83%) 28 (78%) Disease-free
Left distal femur No Recurrence 48 25 (83%) 31 (86%) Disease-free
Left distal femur No Primary 44 26 (87%) 30 (83%) Disease-free
Right proximal tibia No Recurrence 38 29 (97%) 35 (97%) Disease-free
Left proximal tibia No Primary 48 26 (87%) 30 (83%) Disease-free
Right proximal tibia No Primary 48 27 (90%) 33 (92%) Disease-free